Cargando…
Targeting dendritic cells in situ for breast cancer immunotherapy
We have recently developed a protein vaccine against breast cancer in which HER2 is delivered to dendritic cells (DCs) in vivo through receptors expressed on their surface. Our results indicate that this is a promising approach to induce durable, broad and integrated immunity against breast cancer.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518515/ https://www.ncbi.nlm.nih.gov/pubmed/23243606 http://dx.doi.org/10.4161/onci.20982 |
| _version_ | 1782252566961192960 |
|---|---|
| author | Wang, Bei |
| author_facet | Wang, Bei |
| author_sort | Wang, Bei |
| collection | PubMed |
| description | We have recently developed a protein vaccine against breast cancer in which HER2 is delivered to dendritic cells (DCs) in vivo through receptors expressed on their surface. Our results indicate that this is a promising approach to induce durable, broad and integrated immunity against breast cancer. |
| format | Online Article Text |
| id | pubmed-3518515 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35185152012-12-14 Targeting dendritic cells in situ for breast cancer immunotherapy Wang, Bei Oncoimmunology Author's View We have recently developed a protein vaccine against breast cancer in which HER2 is delivered to dendritic cells (DCs) in vivo through receptors expressed on their surface. Our results indicate that this is a promising approach to induce durable, broad and integrated immunity against breast cancer. Landes Bioscience 2012-11-01 /pmc/articles/PMC3518515/ /pubmed/23243606 http://dx.doi.org/10.4161/onci.20982 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | Author's View Wang, Bei Targeting dendritic cells in situ for breast cancer immunotherapy |
| title | Targeting dendritic cells in situ for breast cancer immunotherapy |
| title_full | Targeting dendritic cells in situ for breast cancer immunotherapy |
| title_fullStr | Targeting dendritic cells in situ for breast cancer immunotherapy |
| title_full_unstemmed | Targeting dendritic cells in situ for breast cancer immunotherapy |
| title_short | Targeting dendritic cells in situ for breast cancer immunotherapy |
| title_sort | targeting dendritic cells in situ for breast cancer immunotherapy |
| topic | Author's View |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518515/ https://www.ncbi.nlm.nih.gov/pubmed/23243606 http://dx.doi.org/10.4161/onci.20982 |
| work_keys_str_mv | AT wangbei targetingdendriticcellsinsituforbreastcancerimmunotherapy |